Penumbra Inc Stock
Penumbra Inc Stock
Penumbra Inc dominated the market today, gaining €8.70 (3.570%).
Pros and Cons of Penumbra Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Penumbra Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Penumbra Inc | 3.570% | 0.318% | 29.006% | 10.315% | 11.092% | 24.950% | 50.238% |
| Icu Medical Inc. | -0.820% | -4.724% | 9.009% | -17.123% | -17.687% | -20.395% | -24.845% |
| Bio-Rad Labs Inc. A | 0.330% | -4.419% | 1.365% | -14.689% | -12.544% | -30.928% | -40.541% |
| Neogen Corp. | 0.980% | -0.962% | -2.830% | -59.127% | -57.083% | - | - |
News
Penumbra (PEN) Q2 Revenue Jumps 13%
Penumbra (NYSE:PEN), a medical device innovator focused on clot removal and vascular care, reported its second quarter 2025 results on July 29, 2025. The company delivered $339.5 million in GAAP
